(Q44754071)
Statements
Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain (English)
A Llombart-Cussac
A Barnadas
B Ojeda
V Carañana
Y Fernández
J García-Conde
S Alonso
S Montero
J Hornedo
1 February 2004